Abstract 688: Anti-CNTN4 antibody, GENA-104A07 suppresses tumor growth in murine syngeneic tumor models by regulating T cell function
Cha, Mi Young, Houh, Youn Kyung, Kim, Yun Yeon, Kim, Hyunuk, Chung, Joo-Yeon, Park, Kyung Mi, Park, Hansoo
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Get full text
Journal Article
Abstract 492: CNTN4 is a novel immune checkpoint protein that inhibits proliferation of T cell by interacting with APP
Cha, Mi Young, Jeon, Bu-Nam, Jeong, Areum, Chung, Joo-Yeon, Yang, Hyunsuk, Park, Kyung Mi, Park, Hansoo
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Get full text
Journal Article
Abstract 6382: Activation of transcription factors, p65 and NFATc1, mediated by WNT5a, induces up-regulation of novel immune checkpoint CNTN4 expression
Cha, Mi Young, Jeon, Bu-Nam, Kang, Hyeokgu, Park, Kyung Mi, Park, Hansoo
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Get full text
Journal Article
Abstract 580: APP as a novel immune checkpoint: Expression in T cells and its clinical implications for immuno-oncology drug refractory
Cha, Mi Young, Jeon, Bu-Nam, Kim, Gihyeon, Jeong, Areum, Park, Sang-Moo, Park, Kyung Mi, Park, Hansoo
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article
Abstract 7522: Association between the CNTN4 expression and responsiveness to pembrolizumab in gastric cancer
Cha, Mi Young, Kim, Gihyeon, Park, Changho, Jeon, Bu-Nam, Park, Kyung Mi, Park, Hansoo, Ock, Chan-Young
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article
Abstract 740: CNTN4 as a novel target for solid cancer with antibody-drug conjugate
Cha, Mi Young, Kim, Hyunuk, Byun, Seungmin, Ha, Youngeun, Park, Kitae, Yu, Hyunkyung, Jeon, Bu-Nam, Kim, Mira, Moon, Soojung, Park, Kyung Mi, Park, Hansoo
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article
Abstract 2968: Development of anti-APP antibody targeting APP/CNTN4 axis as a novel cancer immunotherapy
Cha, Mi Young, Ha, Youngeun, Jeon, Bu-Nam, Kim, Hyunuk, Kim, Yunyeon, Lee, Jiyeong, Kim, Han-Sol, Jeong, A-Reum, Yu, Hyunkyung, Park, Kyung Mi, Park, Hansoo
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Get full text
Journal Article
Abstract 1868: Novel immune checkpoint inhibitor: In vivo and in vitro efficacy of anti-CNTN4 antibody, GENA-104A16 in the models with increased CNTN4 expression
Cha, Mi Young, Yu, Hyunkyung, Jeon, Bu-Nam, Ha, Youngeun, Kim, Hyunuk, Kim, Yunyeon, Chung, Joo-Yeon, Kim, Gihyeon, Park, Changho, Park, Kyung Mi, Park, Hansoo
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Get full text
Journal Article
Abstract 592: TLT2 expressed on B cells and Bregs suppresses T cell activity, and treatment of the anti-TLT2 antibody, GENA-105S05, induces tumor growth inhibition in a syngeneic mouse model
Cha, Mi Young, Jeon, Bu-Nam, Yang, Hyunsuk, Byun, Seungmin, Jeong, Areum, Chung, Joo-Yeon, Kim, Sanggyun, Park, Kyung Mi, Park, Hansoo
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article
Abstract 2862: Novel immune checkpoint protein CNTN4 and the preclinical efficacy of affinity matured anti-CNTN4 antibody GENA-104A16
Cha, Mi Young, yu, Hnkyung, Jeon, Bu-Nam, Kim, Hyunuk, Ha, Youngeun, Kim, Yunyeon, Chung, Joo-Yeon, Moon, Soojung, Youn, Hyunseong, Kim, Han-sol, Park, Kyung Mi, Park, Hansoo
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article
Abstract 1760: The antibody-drug conjugate GENA-111 conjugated to auristatin F shows therapeutic potency in BCAM positive epithelial cancer
Yu, Hyunkyung, Bellocq, Nathalie, Ha, Youngeun, Kim, Hyunuk, Kim, Yunyeon, Jeon, Bu-Nam, Marx, Léo, Pantin, Mathilde, Yoo, Hyunjin, Byun, Seungmin, Chung, Joo-Yeon, Cha, Mi Young, Garrouste, Patrick, Lévy, Frédéric
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article
Abstract LB-100: Discovery of HM61713 as an orally available and mutant EGFR selective inhibitor
Lee, Kwang-Ok, Cha, Mi Young, Kim, Mira, Song, Ji Yeon, Lee, Jae-Ho, Kim, Young Hoon, Lee, Young-Mi, Suh, Kwee Hyun, Son, Jeewoong
Published in Cancer research (Chicago, Ill.) (01.10.2014)
Published in Cancer research (Chicago, Ill.) (01.10.2014)
Get full text
Journal Article
Abstract LB-389: Antitumor activity of HM781–36B, a highly effective pan -HER inhibitor in erlotinib-resistant NSCLC and other EGFR-dependent cancer models
Cha, Mi Young, Lee, Kwang-Ok, Kim, Young Hun, Suh, Kwee Hyun, Park, Seung Bum, Kim, Maeng Sup, Lee, Gwan Sun
Published in Cancer research (Chicago, Ill.) (15.04.2011)
Published in Cancer research (Chicago, Ill.) (15.04.2011)
Get full text
Journal Article